ロード中...
The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes
Mesenchymal stromal cell (MSC) therapy is a promising tool in the treatment of chronic inflammatory diseases. This has been ascribed to the capacity of MSC to release a large variety of immune-modulatory factors. However, all aspects of the mode of therapeutic MSC action in different diseases remain...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763726/ https://ncbi.nlm.nih.gov/pubmed/31616424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02249 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|